Drug Combination for Treatment of Proliferative Diseases
2017
Abstract
Angiogenesis inhibitory drug combination obtained according to a specific algorithm, preferably a FSC, in which an initial combination of drugs is iteratively adjusted. The drug combination according to the invention may advantageously comprise a RAPTA-C compound. In a more specific case the combination comprises RAPTA-C and eriotinib.
Details
Title
Drug Combination for Treatment of Proliferative Diseases
Author(s)
Nowak-sliwinska, Patrycja ; Dyson, Paul ; Griffioen, Arjan ; Weiss, Andrea ; Van Den Bergh, Hubert ; Ding, Xianting
Date
2017
Keywords
Note
Alternative title(s) :
(de) Arzneimittelkombination zur behandlung proliferativer krankheiten
(fr) Association de médicaments pour le traitement de maladies prolifératives
(en) Drug combination for treatment of proliferative diseases
Other identifier(s)
EPO Family ID: 52875103
Patent number(s)
US2017014372 (A1)
EP3116485 (A2)
WO2015136061 (A3)
WO2015136061 (A2)
EP3116485 (A2)
WO2015136061 (A3)
WO2015136061 (A2)
Record Appears in
Scientific production and competences > SB - School of Basic Sciences > ISIC - Institute of Chemical Sciences and Engineering > UNATTRIBUTED-ISIC - ISIC - Unattributed publications
Scientific production and competences > Non-academic units > TTO - Technology Transfer Office
Work produced at EPFL
Patents
Scientific production and competences > Non-academic units > TTO - Technology Transfer Office
Work produced at EPFL
Patents
Record creation date
2017-05-02